Covered recipient · General Payments record
JONATHAN T MARTINEK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,171.15
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $776.26 | 34 |
| Long term medical supply or device loan | $29.97 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $240.14 | 9 |
| Abbott Laboratories | $202.01 | 3 |
| PFIZER INC. | $133.04 | 10 |
| GlaxoSmithKline, LLC. | $82.07 | 5 |
| ABBVIE INC. | $74.83 | 4 |
| Collegium Pharmaceutical, Inc. | $23.76 | 1 |
| Merck Sharp & Dohme Corporation | $21.27 | 1 |
| Amgen Inc. | $14.84 | 1 |
| Lilly USA, LLC | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201920202023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $29.97 | 04/09/2024 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 1125437951 | CMS |
| Abbott Laboratories | $153.89 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125304915 | CMS |
| Abbott Laboratories | $18.15 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125304913 | CMS |
| ABBVIE INC. | $23.92 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104975257 | CMS |
| ABBVIE INC. | $19.74 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104975259 | CMS |
| ABBVIE INC. | $14.80 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104975261 | CMS |
| ABBVIE INC. | $16.37 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104975263 | CMS |
| Amgen Inc. | $14.84 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117320032 | CMS |
| Collegium Pharmaceutical, Inc. | $23.76 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135276222 | CMS |
| GlaxoSmithKline, LLC. | $18.24 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116582513 | CMS |
| GlaxoSmithKline, LLC. | $16.56 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116507701 | CMS |
| GlaxoSmithKline, LLC. | $16.08 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116390872 | CMS |
| GlaxoSmithKline, LLC. | $15.19 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116240488 | CMS |
| GlaxoSmithKline, LLC. | $16.00 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116243167 | CMS |
| Lilly USA, LLC | $14.27 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135088375 | CMS |
| Merck Sharp & Dohme LLC | $21.27 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141587182 | CMS |
| Novo Nordisk Inc | $5.52 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096590721 | CMS |
| Novo Nordisk Inc | $23.52 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096632210 | CMS |
| Novo Nordisk Inc | $19.54 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097078593 | CMS |
| Novo Nordisk Inc | $103.91 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097709657 | CMS |
| Novo Nordisk Inc | $13.01 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097647610 | CMS |
| Novo Nordisk Inc | $5.85 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096757032 | CMS |
| Novo Nordisk Inc | $22.75 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096611910 | CMS |
| Novo Nordisk Inc | $25.14 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097327419 | CMS |
| Novo Nordisk Inc | $20.90 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096682733 | CMS |
| PFIZER INC. | $19.14 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132020183 | CMS |
| PFIZER INC. | $20.10 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131222803 | CMS |
| PFIZER INC. | $6.32 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130906063 | CMS |
| PFIZER INC. | $1.56 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130906755 | CMS |
| PFIZER INC. | $7.07 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130931832 | CMS |
| PFIZER INC. | $20.18 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132034540 | CMS |
| PFIZER INC. | $19.66 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131833852 | CMS |
| PFIZER INC. | $1.07 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130945962 | CMS |
| PFIZER INC. | $8.06 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130956921 | CMS |
| PFIZER INC. | $29.88 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131144702 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.